Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | GLP1R | P43220 | 8/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9340071 | 0.85 | EPHX1 (0.52) | MEN1KMT2AEPHX1SMN1; SMN2LMNA | |
| SCHEMBL29721054 | 0.85 | MEN1 (0.44) | MEN1KMT2AEPHX1SMN1; SMN2LMNA | |
| SCHEMBL24340304 | 0.85 | MEN1 (0.44) | MEN1KMT2AEPHX1SMN1; SMN2LMNA | |
| SCHEMBL29240391 | 0.85 | MEN1 (0.44) | MEN1KMT2AEPHX1SMN1; SMN2LMNA | |
| SCHEMBL30864659 | 0.82 | MEN1 (0.46) | MEN1KMT2ASMN1; SMN2EPHX2CYP2C19 | |
| SCHEMBL13699512 | 0.82 | MEN1 (0.49) | MEN1KMT2AEPHX1ALDH1A1 | |
| SCHEMBL21071644 | 0.82 | MEN1 (0.49) | MEN1KMT2AEPHX1ALDH1A1 | |
| SCHEMBL21069640 | 0.82 | MEN1 (0.49) | MEN1KMT2AEPHX1ALDH1A1 | |
| SCHEMBL23728812 | 0.82 | MEN1 (0.49) | MEN1KMT2AEPHX1ALDH1A1 | |
| SCHEMBL1261192 | 0.82 | MEN1 (0.49) | MEN1KMT2AEPHX1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4419540-A1 | IMMUNOMODULATORS | Bristol-Myers Squibb Company (US) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023069994-A1 | IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-04-27 | — | — | WO | disclosed |